1-4 of 4
Davendra Segara
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract OT2-01-10: WinPro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early-stage hormone receptor-positive breast cancer

Teesha Downton, Davendra Segara, Andrew Ong, Janne Bingham, Emma-Kate Carson, Julia Chen, Kate Middleton, Geoffrey Lindeman, Andrew Parker, Elgene Lim
Journal: Cancer Research
Cancer Res (2023) 83 (5_Supplement): OT2-01-10.
https://doi.org/10.1158/1538-7445.SABCS22-OT2-01-10
Published: 01 March 2023
View article titled, Abstract OT2-01-10: WinPro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early-stage hormone receptor-positive breast cancer
Journal Articles

Abstract OT-09-07: Winpro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer

Brandon Lau, Davendra Segara, Andrew Ong, Janne Bingham, Belinda Kiely, Emma-Kate Carson, Julia Chen, Cindy Mak, Sanjay Warrier, Mun Hui, Kate Middleton, Andrew Parker, Bruce Mann, Geoffrey Lindeman, Wayne Tilley, Elgene Lim
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): OT-09-07.
https://doi.org/10.1158/1538-7445.SABCS20-OT-09-07
Published: 15 February 2021
View article titled, Abstract OT-09-07: Winpro: A window of opportunity study of endocrine therapy with and without prometrium in postmenopausal women with early stage hormone receptor-positive breast cancer
Journal Articles

Abstract PS18-17: Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer

Neil Portman, Heloisa Milioli, Sarah Alexandrou, Rhiannon Coulson, Aliza Yong, Kristine Fernandez, KeeMing Chia, Ensar Halilovic, Davendra Segara, Andrew Parker, Sue Haupt, Ygal Haupt, Wayne Tilley, Alex Swarbrick, Liz Caldon, Elgene Lim
Journal: Cancer Research
Cancer Res (2021) 81 (4_Supplement): PS18-17.
https://doi.org/10.1158/1538-7445.SABCS20-PS18-17
Published: 15 February 2021
View article titled, Abstract PS18-17: Mdm2 inhibition synergises with endocrine therapy or cdk4/6 inhibition for the treatment of estrogen receptor-positive breast cancer
Journal Articles

Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer

Amelia A. Peters, Grant Buchanan, Carmela Ricciardelli, Tina Bianco-Miotto, Margaret M. Centenera, Jonathan M. Harris, Shalini Jindal, Davendra Segara, Li Jia, Nicole L. Moore, Susan M. Henshall, Stephen N. Birrell, Gerhard A. Coetzee, Robert L. Sutherland, Lisa M. Butler, Wayne D. Tilley
Journal: Cancer Research
Cancer Res (2009) 69 (15): 6131–6140.
https://doi.org/10.1158/0008-5472.CAN-09-0452
Published: 29 July 2009
View article titled, Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Open the PDF for Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer in another window
Includes: Supplementary data